
Sign up to save your podcasts
Or


Karen M. Winkfield, MD, PhD, Associate Professor of Radiation Oncology, Comprehensive Cancer Center at Wake Forest Baptist Health discusses identifying factors associated with prognosis and staging in a MALT lymphoma and how to identify factors predicting local failure following H Pylori eradication therapy.
By American Society of Clinical Oncology (ASCO)4.5
3131 ratings
Karen M. Winkfield, MD, PhD, Associate Professor of Radiation Oncology, Comprehensive Cancer Center at Wake Forest Baptist Health discusses identifying factors associated with prognosis and staging in a MALT lymphoma and how to identify factors predicting local failure following H Pylori eradication therapy.

320 Listeners

39 Listeners

17 Listeners

59 Listeners

3,367 Listeners

46 Listeners

338 Listeners

23 Listeners

228 Listeners

61 Listeners

496 Listeners

65 Listeners

196 Listeners

46 Listeners

4,470 Listeners